Table 2.
α2-PI, PIC, and changes in intracranial hematoma volume
| Total (n = 30) | Good outcome group (n = 28) | Poor outcome group (n = 2) | Difference (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| Hematoma volume at 1st CT scan, median (IQR), mL | 9.7 (0.7–17.5) | 9.7 (0.6–16.2 | 47.2 (1.3–93.1) | − 37.5 (− 65.1– − 2.2) | ||||
| Hematoma volume at 2nd CT scan, median (IQR), mL | 20.2 (5.6–48.0) | 20.2 (5.3–46.9) | 103.1 (12.1–194.1) | − 82.9 (− 127.7– − 24.7) | ||||
| Change in hematoma volume, median (IQR), mL | 10.6 (2.3–26.0) | 8.9 (2.2–25.1) | 55.9 (10.8–101.0) | − 47.0 (− 71.5– − 13.5) | ||||
| Interval between CT scans, median (IQR), minutes | 163 (133–194) | 163 (128–195) | 160 (136–184) | 3 (− 69–80) | ||||
| Plasma α2-PI activity on admission, median (IQR), % | 91 (80–98) | 92 (81–99) | 82 (77–86) | 10 (− 11–31) | ||||
| Plasma PIC level on admission, median (IQR), μg/mL | 5.1 (2.5–9.4) | 4.9 (2.4–8.3) | 27.0 (13.0–40.9) | − 22.1 (− 30.7– − 11.0) | ||||
CT Computed tomography, IQR Interquartile range, PIC Plasmin-alpha 2-plasmin inhibitor complex, α2-PI Alpha 2-plasmin inhibitor